Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury
NCT01502631 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 8, 2012
- Completion date
- September 21, 2014
- Enrollment
- 65 (actual)
- Sites
- 67
Conditions
As the registry lists them; a condition with its own page is linked.
acute spinal cord injury